Roivant Sciences Ltd (ROIV)
Debt-to-capital ratio
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 4,687,600 | 5,968,580 | 1,157,770 | 1,656,940 | 1,797,790 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
March 31, 2025 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $4,687,600K)
= 0.00
The debt-to-capital ratio of Roivant Sciences Ltd has been consistently at 0.00 from March 31, 2021, to March 31, 2024, indicating that the company has been funding its operations mainly through equity rather than debt during these years. As of March 31, 2025, the ratio is not available, denoted by an em dash, possibly implying a change in the financial structure that requires further investigation to determine the impact on the company's leverage position. The stable low debt-to-capital ratio indicates a conservative approach to financing, which may reflect positively on the company's financial health and risk management strategies.
Peer comparison
Mar 31, 2025